Home Contact Us Site Map
Search for:
About Us Services News Calendar
Health Info Find a Job Find a Physician
Hospitals
Children’s Hospital
Clinic
Health Plans
Foundation
Ways to Give
Areas of Excellence
Web Nursery
For Patients and Visitors
E-mail a Patient
Patient Pre-registration
For Physicians,
Co-workers and Volunteers
Libraries
Vendor Resources
Privacy Practices and Web Use Information
 
Home > News > 2005 News 


St. John's Medical Research conducts rheumatoid arthritis study

Oct. 1, 2005


More than 2 million Americans suffer from mild to severe rheumatoid arthritis (RA).  St. John’s Medical Research in Springfield is currently conducting a Phase III clinical study for the treatment of RA, known as the Rheumatoid Arthritis Study.  Dr. Anne Winkler is leading this effort locally and is currently enrolling patients into the study.

 

Those interested in learning more about the Rheumatoid Arthritis Study or in finding out if they may be eligible to participate may call St. John’s Medical Research at 417-841-0250 or toll-free at 1-866-207-0167.

 

Rheumatoid arthritis is an inflammation of the lining of the joints.  This inflammation is what can cause pain and swelling – the most common symptoms of RA.  Over time, inflammation may also cause permanent damage to the bone and cartilage of joints.  This damage may limit the function of the affected joints.

 

To address their RA pain, sufferers often use aspirin and other over-the-counter pain relievers.  If these pain relievers do not provide adequate relief, physicians may also prescribe medications.

 

No one knows for sure what causes RA, but medical researchers believe RA is the results of a person’s immune system responding incorrectly.  Usually, the immune system keeps a person healthy by fighting off germs and infections.  However, in people with RA, it is believed that the immune system attacks healthy joint tissue by mistake, causing the inflammation – and therefore the swelling, pain, and joint damage – of rheumatoid arthritis. 

 

People who may be eligible to participate in the Rheumatoid Arthritis Study include men or women who are 18 years of age or older and have a confirmed diagnosis of moderate-to-severe, active RA for six months or more.  In addition to the opportunity to possibly receive the investigational drug, study participation includes close monitoring of the patient’s rheumatoid arthritis and study-related care at no cost to the participant.

 

For more information please contact:

St. John’s Medical Research

417-841-0250 (phone)

1-866-207-0167 (toll-free phone)

ehicks@sprg.mercy.net

 

 Home
...................................
 Join Media List
...................................
 Search News
    Releases

...................................
 Contact Media  
    Team

...................................
 St. John's Facts &
     Figures

...................................
 Publications
...................................
 Media Team

Cora Scott
Media Relations Director
Office: 417-820-2426
Cell: 417-830-7271
cora.scott@mercy.net


Angela Garrison
Media Relations Specialist
Office: 417-820-2171
Cell: 417-224-0906
angela.garrison@mercy.net


Mike Peters
VP, Public Affairs
Office: 417-820-3250
michael.peters@mercy.net

A member of the
Sisters of Mercy Health System